Clinical Trial Update: De-escalation Radiation Strategy After NAC in Combination With ICI in LAHNSCC [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial is evaluating a de-escalation radiation strategy after neoadjuvant chemotherapy in combination with an immune checkpoint inhibi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Ruijin Hospital | Conditions: Locally Advanced Head and Neck Squamous Cell Carcinoma | Phase 1, Phase 2 | Status: RECRUITING